ESMO 2018 | Determining the quality of life in long-term survivors of ovarian cancer

Jalid Sehouli

Speaking from the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, Jalid Sehouli, MD, of the Charité University of Medicine Berlin, Berlin, Germany, discusses a study to helping determine the quality of life in women with long-term survival from ovarian cancer, and suggests a role for preoperative c-reactive protein in predicting survival among long-term survivors of ovarian cancer.

Share this video